177 related articles for article (PubMed ID: 11953351)
21. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P
Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968
[TBL] [Abstract][Full Text] [Related]
22. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
Rösch W; Vinson B; Sassin I
Z Gastroenterol; 2002 Jun; 40(6):401-8. PubMed ID: 12055663
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of a herbal preparation in patients with functional dyspepsia: a meta-analysis of double-blind, randomized, clinical trials.
Gundermann KJ; Godehardt E; Ulbrich M
Adv Ther; 2003; 20(1):43-9. PubMed ID: 12772817
[TBL] [Abstract][Full Text] [Related]
24. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
Halter F; Staub P; Hammer B; Guyot J; Miazza BM
J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
[TBL] [Abstract][Full Text] [Related]
25. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
[TBL] [Abstract][Full Text] [Related]
26. Treatment of uninvestigated dyspepsia with cisapride for patients with negative Helicobacter pylori serologies.
Kearney DJ; Avins AL; McQuaid KR
Am J Gastroenterol; 2000 Sep; 95(9):2212-7. PubMed ID: 11007220
[TBL] [Abstract][Full Text] [Related]
27. [Drug therapy of functional dyspepsia. A review based on Cochrane Reviews].
Hansen JM; Bytzer P
Ugeskr Laeger; 2001 Sep; 163(37):4987-9. PubMed ID: 11573368
[No Abstract] [Full Text] [Related]
28. [Management of gastroparesis and functional dyspepsia after cisapride withdrawal].
Louis H
Rev Med Brux; 2012 Sep; 33(4):425-9. PubMed ID: 23091951
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological interventions for non-ulcer dyspepsia.
Soo S; Moayyedi P; Deeks J; Delaney B; Innes M; Forman D
Cochrane Database Syst Rev; 2000; (2):CD001960. PubMed ID: 10796840
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
[TBL] [Abstract][Full Text] [Related]
31. [Functional dyspepsia: the past, the present and the Rome III classification].
Buzás GM
Orv Hetil; 2007 Aug; 148(33):1573-9. PubMed ID: 17686677
[TBL] [Abstract][Full Text] [Related]
32. Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study.
Halter F; Miazza B; Brignoli R
Scand J Gastroenterol; 1994 Jul; 29(7):618-23. PubMed ID: 7939398
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of a new medical device with domperidone in functional dyspepsia: a randomized, cross-over, controlled study].
Gallo A; Giovinale M; Fonnesu C; Covino M; Montalto M; Gasbarrini G
Minerva Med; 2011 Apr; 102(2):133-9. PubMed ID: 21483400
[TBL] [Abstract][Full Text] [Related]
34. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
[TBL] [Abstract][Full Text] [Related]
35. Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia.
Gonlachanvit S; Mahachai V; Chaiwatanarat T; Kullavanijaya P
J Med Assoc Thai; 2005 May; 88(5):660-7. PubMed ID: 16149685
[TBL] [Abstract][Full Text] [Related]
36. Clinical trials in nonulcer dyspepsia (NUD): a cautionary note. A closer look at "a double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia".
Champion MC
Can J Gastroenterol; 1997 Mar; 11(2):125-6. PubMed ID: 9113811
[No Abstract] [Full Text] [Related]
37. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
De Nutte N; Van Ganse W; Witterhulghe M; Defrance P
Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906
[TBL] [Abstract][Full Text] [Related]
38. [Prokinetics of gastrointestinal system; its newer aspects with regard to motillity stimulants].
Hongo M; Satake M
Nihon Rinsho; 2002 Feb; 60 Suppl 2():382-8. PubMed ID: 11979811
[No Abstract] [Full Text] [Related]
39. Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study.
Deruyttere M; Lepoutre L; Heylen H; Samain H; Pennoit H
Clin Ther; 1987; 10(1):44-51. PubMed ID: 3329964
[TBL] [Abstract][Full Text] [Related]
40. Histamine H2 antagonists for functional dyspepsia: A protocol for a systematic review and meta-analysis.
Li J; Wang F; Lv L; Xu L; Zeng E; Tang X
Medicine (Baltimore); 2019 Nov; 98(47):e18128. PubMed ID: 31764854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
